Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

NCT06914141 · clinicaltrials.gov ↗

COMPLETED

Status

28118

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
HFpEF - Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: Tirzepatide
DRUG: Semaglutide

Sponsor

Brigham and Women's Hospital